CRISPR-Based Testing Feasible for SARS-CoV-2 Screening
Study finds technology shows concordance with PCR testing and can detect leading edge of outbreak in asymptomatic people
CPR Quality Impacts Survival in In-Hospital Cardiac Arrest
Number of pauses greater than 10 seconds during resuscitation linked to survival for four end points
Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma
Progression-free survival longer and response rate greater for cabozantinib versus sunitinib in phase 2 trial in adults with PRCC
Methylprednisolone Added to IVIG May Cut Fever in MIS-C
IV immunoglobulins plus methylprednisolone associated with lower risk for treatment failure compared with immunoglobulins alone
Zinc, Ascorbic Acid Do Not Cut Symptom Duration in SARS-CoV-2
No difference in length of time required to achieve 50 percent reduction in symptoms seen with supplements versus usual care
Fauci Given $1 Million Award for ‘Defending Science’
The prize from the Dan David Foundation in Israel was announced Monday
AstraZeneca COVID-19 Vaccine Approved by the WHO
This is the second such approval from the WHO, which gave the Pfizer vaccine the green light in December
High-Intensity Strength Training No Added Benefit for Knee Osteoarthritis
Findings compared with low-intensity strength training or control condition
Eye Abnormalities Identified in Severe COVID-19 Patients
Seven percent of patients in a cohort of 129 with severe COVID-19 presented with abnormal MRI findings of the globe of the eye
USPSTF Advises Screening for Gestational Diabetes Mellitus
GDM screening recommended at or after, but not before, 24 weeks of gestation in asymptomatic pregnant individuals
